BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19236764)

  • 21. CD34/CD133 enriched bone marrow progenitor cells promote neovascularization of tissue engineered constructs in vivo.
    Herrmann M; Binder A; Menzel U; Zeiter S; Alini M; Verrier S
    Stem Cell Res; 2014 Nov; 13(3 Pt A):465-77. PubMed ID: 25460607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence and distribution of CD133 and CD34 antigen expression in proximal tubule epithelial cells during ischemia/reperfusion injury in rats].
    Chen FM; Jiang XN; Shi JQ; Yan B; Ren DS; Gu J; Li DB; Zhang Y; Shen J; Liang J; Wang Y
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2864-8. PubMed ID: 21162801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations.
    Yeo C; Saunders N; Locca D; Flett A; Preston M; Brookman P; Davy B; Mathur A; Agrawal S
    Regen Med; 2009 Sep; 4(5):689-96. PubMed ID: 19761394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.
    Chen Y; Lu B; Wang J; Chen S; Lin Z; Ma X; Liu Y; Zhao B; Chen Y
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):319-26. PubMed ID: 25444027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased number of circulating progenitor cells after implantation of ventricular assist devices.
    Manginas A; Tsiavou A; Sfyrakis P; Giamouzis G; Tsourelis L; Leontiadis E; Degiannis D; Cokkinos DV; Alivizatos PA
    J Heart Lung Transplant; 2009 Jul; 28(7):710-7. PubMed ID: 19560700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel population of repair cells identified in the stroma of the human cornea.
    Thill M; Schlagner K; Altenähr S; Ergün S; Faragher RG; Kilic N; Bednarz J; Vohwinkel G; Rogiers X; Hossfeld DK; Richard G; Gehling UM
    Stem Cells Dev; 2007 Oct; 16(5):733-45. PubMed ID: 17999595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of CD271 in bone marrow mesenchymal stem cells--changes by cryopreservation.
    Aoyagi K; Yamazaki Y; Matsuo A; Shimakura Y; Takeda A; Uchinuma E
    J Craniofac Surg; 2010 May; 21(3):666-78. PubMed ID: 20485027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation.
    Jaime-Pérez JC; Guillermo-Villanueva VA; Méndez-Ramírez N; Chapa-Rodríguez A; Gutiérrez-Aguirre H; Gómez-Almaguer D
    Transfusion; 2009 Nov; 49(11):2390-4. PubMed ID: 19903294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
    Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood.
    Lazarova P; Wu Q; Kvalheim G; Suo Z; Haakenstad KW; Metodiev K; Nesland JM
    Int J Immunopathol Pharmacol; 2006; 19(1):49-56. PubMed ID: 16569339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo.
    Popa ER; Harmsen MC; Tio RA; van der Strate BW; Brouwer LA; Schipper M; Koerts J; De Jongste MJ; Hazenberg A; Hendriks M; van Luyn MJ
    J Mol Cell Cardiol; 2006 Jul; 41(1):86-96. PubMed ID: 16780869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells.
    Jarocha D; Lukasiewicz E; Majka M
    Folia Histochem Cytobiol; 2008; 46(3):307-14. PubMed ID: 19056534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.
    Bartling B; Koch A; Simm A; Scheubel R; Silber RE; Santos AN
    Int J Mol Med; 2010 Jan; 25(1):89-96. PubMed ID: 19956906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance of serum NGF level and CD271 expression in patients with acute B lymphoid leukemia].
    Han XH; Xu KL; Zeng LY; Li ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1273-6. PubMed ID: 22040987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue.
    Busser H; Najar M; Raicevic G; Pieters K; Velez Pombo R; Philippart P; Meuleman N; Bron D; Lagneaux L
    Stem Cells Dev; 2015 Sep; 24(18):2142-57. PubMed ID: 26086188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD271 as a marker for mesenchymal stem cells in bone marrow versus umbilical cord blood.
    Watson JT; Foo T; Wu J; Moed BR; Thorpe M; Schon L; Zhang Z
    Cells Tissues Organs; 2013; 197(6):496-504. PubMed ID: 23689142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic superiority for cartilage repair by CD271-positive marrow stromal cell transplantation.
    Mifune Y; Matsumoto T; Murasawa S; Kawamoto A; Kuroda R; Shoji T; Kuroda T; Fukui T; Kawakami Y; Kurosaka M; Asahara T
    Cell Transplant; 2013; 22(7):1201-11. PubMed ID: 23044363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic Potential of Bone Marrow Derived CD133
    Sasse S; Skorska A; Lux CA; Steinhoff G; David R; Gaebel R
    Cells; 2019 Dec; 9(1):. PubMed ID: 31892273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
    Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
    Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.